Protara Therapeutics, Inc. Proceeds from Issuance of Private Placement
Protara Therapeutics, Inc. (TARA) reported Proceeds from Issuance of Private Placement of $42.50 million for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-07-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2021-03-11
- Protara Therapeutics, Inc. proceeds from issuance of private placement for the quarter ending 2019-12-31 was $1.00.
- Protara Therapeutics, Inc. proceeds from issuance of private placement for fiscal 2019 was $500.00K.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2020-06-30 | $42.50M 10-Q · filed 2020-07-31 | |||
| 2019-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $500.00K 10-K · filed 2021-03-11 | ||
| 2019-09-30 | $500.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |